These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7448106)

  • 21. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
    Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
    Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
    Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous infusions of propofol administered to dogs: effects on ICG and propofol disposition.
    Sear JW; Diedericks J; Foex P
    Br J Anaesth; 1994 Apr; 72(4):451-5. PubMed ID: 8155450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA; James JA; Read AE
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
    Nattel S; Gagne G; Pineau M
    Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of lignocaine in children following caudal anaesthesia.
    Ecoffey C; Desparmet J; Berdeaux A; Maury M; Giudicelli JF; Saint-Maurice C
    Br J Anaesth; 1984 Dec; 56(12):1399-402. PubMed ID: 6498050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of lignocaine on arginine-vasopressin plasma levels: baseline or induced by frusemide.
    Gariépy L; Larose P; Bailey B; du Souich P
    Br J Pharmacol; 1992 Jun; 106(2):470-5. PubMed ID: 1393272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiacetarsamide in dogs: disposition kinetics and correlations with selected indocyanine green kinetic values.
    Holmes RA; Wilson RC; McCall JW
    Am J Vet Res; 1986 Jun; 47(6):1338-40. PubMed ID: 3729137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a recirculatory physiological model of the myocardial concentrations of lignocaine after intravenous administration in sheep.
    Upton RN; Zheng DA; Grant C; Martinez AM
    J Pharm Pharmacol; 2000 Feb; 52(2):181-9. PubMed ID: 10714948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lignocaine therapy after acute myocardial infarction.
    Chopra MP; Portal RW; Aber CP
    Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of hepatic function in cystic fibrosis by lidocaine metabolism.
    Gremse DA; Sindel LJ; Hoff CJ; Wells DJ; Boerth RC
    J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):434-7. PubMed ID: 11396809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
    Davison R; Parker M; Atkinson AJ
    Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial uptake of lignocaine: pharmacokinetics and pharmacodynamics in the isolated perfused heart of the rabbit.
    Mazoit JX; Kantelip JP; Orhant EE; Talmant JM
    Br J Pharmacol; 1990 Dec; 101(4):843-6. PubMed ID: 2085708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.